TUCSON, Ariz., Oct. 17, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that it will report financial results for the third quarter of 2019 after the market close on Thursday, November 7, 2019. The company's management will host a conference call at 4:30 p.m. ET that same da

SAN DIEGO, Oct. 17, 2019 /PRNewswire/ -- Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat serious inflammatory diseases, today announced that it has completed enrollment in RIST4721-201, a Phase 2a study to evaluate the efficacy and safety of RIST4721 in patients with palmoplantar pustulosis.

NEW YORK, Oct. 17, 2019 /PRNewswire/ -- The Rory Staunton Foundation for Sepsis Prevention has been awarded a major federal contract inten

NEW YORK, Oct. 17, 2019 /PRNewswire/ -- The Starr Foundation announced the gift of a $3 million grant to Hospital for Special Surgery (HSS) to establish the C.V. Starr Endowed Chair in Pain Management. This commitment will provide support to enhance pain management research, program development and physician education at HSS.

BEIJING, Oct. 17, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the special committee (the "Special Committee") of the Company's board of directors (the "Board") has retained Duf

ALISO VIEJO, Calif., Oct. 17, 2019 /PRNewswire/ -- Metagenics, Inc., a health sciences company, announced today the release of Hemp Advantage Plus, the third formula launched this year in the Metagenics hemp line. Hemp Advantage Plus combines an organic, broad-spectrum hemp extract with palmitoylethanolamide (PEA) in a patent-pending formula.

MIRA LOMA, Calif., Oct. 17, 2019 /PRNewswire/ -- Bridgecom, provider of a HIPAA-compliant, web-based patient outreach management platform, is excited to be attending the California Association of Health Plans Conference in Palm Desert, CA from October 21st – 23rd. For more tha

CARMIEL, Israel, Oct. 17, 2019 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced positive

HOUSTON, Oct. 17, 2019 /PRNewswire/ -- Researchers from Invitae Corporation (NYSE: NVTA), a leading medical genetics company, are presenting data showing the increasing utilit

BOSTON, Oct. 17, 2019 /PRNewswire/ -- Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of